Javelin Pharmaceuticals, Inc. (JAV) Inks $71 Million European Commercialization Partnership
Javelin Pharmaceuticals, Inc. announced today that it has signed an exclusive European marketing partnership for Dyloject(R) (diclofenac sodium for injection)…